Lymphoblastoids cell lines – Derived iPSC line from a 26-year-old myotonic dystrophy type 1 patient carrying (CTG) 200 expansion in the DMPK gene: CHUQi001-A-Reference-Cited by-同舟云学术

Lymphoblastoids cell lines – Derived iPSC line from a 26-year-old myotonic dystrophy type 1 patient carrying (CTG) 200 expansion in the DMPK gene: CHUQi001-A

Published:2018-01 Issue: Volume:26 Page:103-106
ISSN:1873-5061
Container-title:Stem Cell Research
language:en
Short-container-title:Stem Cell Research

Author:

Martineau Laurie^ORCID,Racine Véronique^ORCID,Benichou Siham Ait,Puymirat Jack

Funder

RMGA

MDA.USA

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,General Medicine

Reference4 articles.

1. Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines;Barrett;Stem Cells Transl. Med.,2014

2. Intergenerational contraction of the CTG repeats in 2 families with myotonic dystrophy type 1;Puymirat;Neurology,2009

3. Induction of pluripotent stem cells from adult human fibroblasts by defined factors;Takahashi;Cell,2007

4. Successful use of long-term frozen lymphocytes for the establishment of lymphoblastoid cell lines;Tremblay;Clin. Biochem.,1998

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generation of control iPSC lines CBRCULi008-A and CBRCULi009-A derived from lymphoblastoid cell lines;Stem Cell Research;2023-09

2. Advances in In Vitro Models of Neuromuscular Junction: Focusing on Organ‐on‐a‐Chip, Organoids, and Biohybrid Robotics;Advanced Materials;2023-07-30

3. Generation of four myotonic dystrophy type 1 patient iPSC lines (CBRCULi002-A, CBRCULi003-A, CBRCULi004-A, CBRCULi005-A) and a control (CBRCULi001-A) derived from lymphoblastoids cell lines;Stem Cell Research;2023-03

4. Pluripotent Stem Cells in Disease Modeling and Drug Discovery for Myotonic Dystrophy Type 1;Cells;2023-02-10

5. Generation and characterization of a human induced pluripotent stem cell (iPSC) line from a patient with congenital heart disease (CHD);Stem Cell Research;2022-12